Anti-citrullinated protein antibodies dominate the association of long-term outcomes and anti-modified protein antibodies in rheumatoid arthritis

T. J. van Wesemael; M. Verstappen; R. Knevel; A. H. M. van der Helm-van Mil; R. E. M. Toes; D. van der Woude

doi:10.1016/S2665-9913(22)00095-9

Anti-citrullinated protein antibodies dominate the association of long-term outcomes and anti-modified protein antibodies in rheumatoid arthritis

T. J. van Wesemael
, M. Verstappen
, R. Knevel
, A. H. M. van der Helm-van Mil
, R. E. M. Toes
, D. van der Woude

Leiden University Medical Center

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Original language	English
Pages (from-to)	e316-e317
Journal	The Lancet Rheumatology
Volume	4
Issue number	5
DOIs	https://doi.org/10.1016/S2665-9913(22)00095-9
Publication status	Published - 1 May 2022
Externally published	Yes

Access to Document

10.1016/S2665-9913(22)00095-9

Cite this

@article{a84e5c8803c442e8baf258d5669d367d,

title = "Anti-citrullinated protein antibodies dominate the association of long-term outcomes and anti-modified protein antibodies in rheumatoid arthritis",

author = "\{van Wesemael\}, \{T. J.\} and M. Verstappen and R. Knevel and \{van der Helm-van Mil\}, \{A. H. M.\} and Toes, \{R. E. M.\} and \{van der Woude\}, D.",

year = "2022",

month = may,

day = "1",

doi = "10.1016/S2665-9913(22)00095-9",

language = "English",

volume = "4",

pages = "e316--e317",

journal = "The Lancet Rheumatology",

issn = "2665-9913",

publisher = "Elsevier Ltd",

number = "5",

}

TY - JOUR

T1 - Anti-citrullinated protein antibodies dominate the association of long-term outcomes and anti-modified protein antibodies in rheumatoid arthritis

AU - van Wesemael, T. J.

AU - Verstappen, M.

AU - Knevel, R.

AU - van der Helm-van Mil, A. H. M.

AU - Toes, R. E. M.

AU - van der Woude, D.

PY - 2022/5/1

Y1 - 2022/5/1

UR - https://www.scopus.com/pages/publications/85129846221

U2 - 10.1016/S2665-9913(22)00095-9

DO - 10.1016/S2665-9913(22)00095-9

M3 - Comment/Letter to the editor

SN - 2665-9913

VL - 4

SP - e316-e317

JO - The Lancet Rheumatology

JF - The Lancet Rheumatology

IS - 5

ER -

Anti-citrullinated protein antibodies dominate the association of long-term outcomes and anti-modified protein antibodies in rheumatoid arthritis

Access to Document

Other files and links

Cite this